M. Nitta et al. / Tetrahedron 61 (2005) 6073–6081
6079
4.2.1. 2-(1,3-Diazaazulen-2-yl)iminotriphenylphosphor-
ane (9). Pale yellow prisms; mp 212–213 8C (decomp.)
(from AcOEt); 1H NMR (600 MHz) d 7.31 (1H, t, JZ
9.9 Hz, H-6), 7.44 (6H, ddd, JZ7.8, 7.5, 2.9 Hz, m-Ph), 7.53
(3H, td, JZ7.5, 1.7 Hz, p-Ph), 7.58 (2H, dd, JZ10.7,
9.9 Hz, H-5 and H-7), 7.93 (6H, dd, JZ7.8, 1.7 Hz, o-Ph),
7.94 (2H, d, JZ10.7 Hz, H-4 and H-8); 13C NMR
(150.9 MHz) d 124.6 (C-4 and C-8), 128.5 (JPCZ12.2 Hz,
m-Ph), 128.8 (JPCZ100.1 Hz, i-Ph), 129.4 (C-6), 132.1
(JPCZ2.6 Hz, p-Ph), 133.4 (JPCZ10.1 Hz, o-Ph), 133.6
(C-5 and C-7), 165.1 (C-2); 31P NMR (109.3 MHz) d 16.97;
IR (CHCl3, cmK1) 1549, 1470, 1438, 1364, 1114, 957, 926,
882; MS m/z 406 (MCCH); Anal. calcd for C26H21N3P: C,
77.02; H, 4.97; N, 10.36. Found: C, 76.87; H, 4.95; N, 10.46.
163.0, 166.5; IR (KBr, cmK1) 1746, 1683; MS m/z 336
(MCCH); Anal. calcd for C16H9N5O4–1/4CH2Cl2: C,
54.75; H, 2.69; N, 19.64. Found: C, 54.75; H, 2.80; N, 19.39.
4.4.2. 3-(4-Nitrophenyl)-2-(4-nitorophenyl)iminocyclo-
hepta[4,5]imidazo[1,2-a]-1,3,5-triazine-4-one (6b). Red
prisms; mp 258–260 8C (decomp.) (from CHCl3); 13C
NMR (150.9 MHz, DMSO-d6) d 123.6, 123.8, 124.5,
124.9, 130.1, 134.6, 137.3, 138.4, 141.5, 142.1, 145.8,
147.2, 147.8, 149.3, 154.0, 160.1, 168.2, 175.2; IR (CHCl3,
cmK1) 1734; MS m/z 456 (MCCH); Anal. calcd for
C22H13N7O5–CHCl3: C, 48.06; H, 2.46; N, 17.06. Found: C,
48.32; H, 2.58; N, 17.30.
4.5. Preparation of urea 15a
4.3. Preparation of 5a and 6a
A solution of 8 (73 mg, 0.5 mmol) and 10a (179 mg,
1.5 mmol), and ZnCl2 (68 mg, 0.5 mmol) in dioxane
(40 mL) was heated under reflux for 50 h. After evaporation
of the solvent, the reaction mixture was washed with EtOH,
the EtOH layer was concentrated to give 15a (106 mg,
80%). A similar reaction in the absence of ZnCl2 afforded
15a (45 mg, 34%), which is identified on the basis of
comparison of the physical data reported previously.17
A solution of 9 (810 mg, 2.0 mmol) and 10a (714 mg,
6.0 mmol) in a solvent (100 mL) indicated in Table 1 was
refluxed for an adequate time. After evaporation of the
solvent, the residue was dissolved in CH2Cl2, the insoluble
material was col0lected by filtration to give N-(1,3-
diazaazuln-2-yl)-N -phenylurea 15a, and the filtrate was
separated by column chromatography on SiO2. The
fractions eluted with AcOEt gave 6a, and the fractions
eluted with acetone gave 5a. The results are summarized in
Table 1.
4.6. Reaction of 15a with 10a
A mixture of 15a (26 mg, 0.1 mmol) and 10a (24 mg,
0.2 mmol) in the presence or absence of ZnCl2 (14 mg,
0.1 mmol) in dioxane (40 mL) was heated under reflux for
50 h. The reaction mixture was concentrated and the residue
was washed with EtOH. The collected EtOH solution was
concentrated and 15a was isolated in 83% (in the presence
of ZnCl2) and 76% (in the absence of ZnCl2).
4.3.1. 3-Phenylcyclohepta[4,5]imidazo[1,2-a]-1,3,5-tri-
azine-2,4(3H)-dione (5a). Yellow needles; mp 228–
230 8C (decomp.) (from CH2CL2/Et2O); 13C NMR
(150.9 MHz, DMSO-d6) d 124.6, 128.2, 128.6, 128.9,
134.5, 135.6, 138.7, 139.0, 142.7, 145.1, 147.9, 155.0,
162.7, 166.3; IR (KBr, cmK1) 1739, 1707; MS m/z 290
(MC); Anal. calcd for C16H10N4O2–1/4H2O: C, 65.19; H,
3.59; N, 19.01. Found: C, 65.20; H, 3.23; N, 19.14.
4.7. Preparation of 7a
4.3.2.
3-Phenyl-2-phenyliminocyclohepta[4,5]imi-
A solution of 5a (2.9 mg, 0.1 mL) and MeI (2 mL) in
(CH2Cl)2 (4 mL) in a sealed tube was heated at 100 8C for
3 h. The solvent was evaporated and the residue was
dissolved in Ac2O (3 mL) and treated with 42% aq. HBF4
(0.6 mL). To the solution was added ether (5 mL) and
precipitates were collected by filtration to give 7a (36 mg,
92%).
dazo[1,2-a]-1,3,5-triazine-4-one (6a). Dark red prisms;
mp 222–223 8C (decomp) (from AcOEt); 13C NMR
(150.9 MHz) 13C NMR (150.9 MHz) d 122.2, 123.0,
123.1, 128.3, 128.5, 128.7, 129.5, 133.5, 135.7, 136.2,
137.9, 141.3, 146.1, 147.7, 148.0, 148.4, 159.7, 168.2; IR
(CHCl3, cmK1) 1728; MS m/z 366 (MCCH); Anal. calcd
for C22H15N5O: C, 72.32; H, 4.14; N, 19.17. Found: C,
72.02; H, 4.12; N, 19.05.
4.7.1. 1-Methyl-3-phenylcyclohepta[4,5]imidazo[1,2-a]-
1,3,5-triazine-2,4(3H)-dionylium tetrafluoroborate (7a).
Colorless needles; mp 289–291 8C (decomp.) (from
CH3CN/Et2O.); 13C NMR (150.9 MHz, CD3CN) d 32.1,
96.1, 128.7, 130.4, 130.7, 133.7, 134.8, 142.0, 145.0, 147.0,
147.2, 147.7, 148.2, 155.3, 162.8; IR (CHCl3, cmK1) 1726,
1084; MS m/z 305 (MCKBF4). HRMS calcd for
C17H13N4O2BF4: 305.1060 (MKBF4). Found: 305.1021
(MCKBF4). Anal calcd for C17H13N4O2BF4: C, 52.07; H,
3.34; N, 14.29. Found: C, 52.04, H, 3.53; N, 13.95.
4.4. Preparation of 5b and 6b
A solution of 9 (810 mg, 2.0 mmol) and 10b (984 mg,
6.0 mmol) in toluene–dioxane (1/1; 100 mL) was refluxed
for 24 h. After evaporation of the toluene, the residue was
dissolved in CH2Cl2, the insoluble material was filtered and
the filtrate was concentrated and separated by column
chromatography on SiO2. The fractions eluted with AcOEt
afforded 6b, and the fractions eluted with acetone gave 5b.
The results are summarized in Table 1.
4.8. Reduction of 5a
4.4.1. 3-(4-Nitrophenyl)cyclohepta[4,5]imidazo[1,2-a]-
1,3,5-triazine-2,4(3H)-dione (5b). Yellow powder; mp
249–252 8C (decomp.) (from AcOEt); 13C NMR
(150.9 MHz, DMSO-d6) d 124.5, 125.3, 130.7, 135.0,
139.4, 139.5, 141.8, 143.2, 145.2, 147.4, 147.9, 154.7,
A solution of 5a (29 mg, 0.1 mmol) and NaBH4 (23 mg,
0.6 mmol) in MeOH (10 mL) was stirred at rt for 30 min.
The reaction mixture was extracted with CH2Cl2 and the
extract was dried over Na2SO4, and concentrated in vacuo.